Abstract
In response to activation, CD4+ T cells upregulate autophagy. However, the functional consequences of that upregulation have not been fully elucidated. In this study, we identify autophagy as a tolerance-avoidance mechanism. Our data show that inhibition of autophagy during CD4+ T cell activation induces a long-lasting state of hypo-responsiveness that is accompanied by the expression of an anergic gene signature. Cells unable to induce autophagy after T cell receptor (TCR) engagement show inefficient mitochondrial respiration and decreased turnover of the protein tyrosine phosphatase PTPN1, which translates into defective TCR-mediated signaling. In vivo, inhibition of autophagy during antigen priming induces T cell anergy and decreases the severity of disease in an experimental autoimmune encephalomyelitis mouse model. Interestingly, CD4+ T cells isolated from the synovial fluid of juvenile idiopathic arthritis patients, while resistant to suboptimal stimulation-induced anergy, can be tolerized with autophagy inhibitors. We propose that autophagy constitutes a tolerance-avoidance mechanism, which determines CD4+ T cell fate. Mocholi et al. show that, following T cell activation, activation of autophagy constitutes a tolerance-avoidance mechanism that, through modulation of cell metabolism and specific signaling pathways, allows T cells to engage in effector responses and avoid anergy. In vivo inhibition of autophagy in T cells induces tolerance and prevents autoimmunity.
Original language | English |
---|---|
Pages (from-to) | 1136-1150 |
Number of pages | 15 |
Journal | Cell Reports |
Volume | 24 |
Issue number | 5 |
DOIs | |
Publication status | Published - 31 Jul 2018 |
Keywords
- anergy
- autoimmunity
- autophagy
- T cell
- Mitochondria/metabolism
- Humans
- Mice, Inbred C57BL
- Cells, Cultured
- Clonal Anergy
- Male
- Autophagy
- Animals
- CD4-Positive T-Lymphocytes/immunology
- Encephalomyelitis, Autoimmune, Experimental/immunology
- Female
- Mice
- Receptors, Antigen, T-Cell/metabolism
- Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism